Prosecution Insights
Browse Companies Examiners Firms Draft Your Response
Home / Amgen Inc. / Complete list
Last updated: October 23, 2026

Amgen Inc.: all pending office actions

← Back to Amgen Inc.

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19281019 SYNTHESIS OF KEY INTERMEDIATE OF KRAS G12C INHIBITOR COMPOUND SIMMONS, CHRIS E 1622 §112Other Non-Final OA 75d Pending Jul 25, 2025
19045308 ROBOTIC SYSTEM FOR PERFORMING PATTERN RECOGNITION-BASED INSPECTION OF PHARMACEUTICAL CONTAINERS RODRIGUEZ, JOSEPH C 3653 §103Other Non-Final OA — Pending Feb 04, 2025
18878828 ANTI-PD-1 ANTIBODY FORMULATIONS OGUNBIYI, OLUWATOSIN A 1645 §103§112 Non-Final OA — Pending Dec 24, 2024
18967331 METHODS OF TREATING HEART FAILURE BY ADMINISTERING OMECAMTIV MECARBIL COHEN, MICHAEL P — §112 Non-Final OA — Pending Dec 03, 2024
18962768 AUTOMATED SYSTEMS AND METHODS FOR FOIL PACKAGING COMPONENTS TECCO, ANDREW M 3731 §102§103 Non-Final OA — Pending Nov 27, 2024
18939822 PROCESSES OF MAKING AND CRYSTALLINE FORMS OF A MDM2 INHIBITOR O DELL, DAVID K 1621 DP Non-Final OA — Pending Nov 07, 2024
18934755 SUSTAINABLE AND MODULAR PACKAGING SYSTEMS FOR CONTAINERS FOR PHARMACEUTICAL USE ORTIZ, RAFAEL ALFREDO 3736 §103§112 Non-Final OA — Pending Nov 01, 2024
18855457 COMPLEMENT-DEPENDENT CYTOTOXICITY METHODS CURRENS, GRANT CARSON 1651 §103 Non-Final OA — Pending Oct 09, 2024
18853977 SYSTEMS AND METHODS FOR REDUCING EXCESS RESOURCE USAGE KESSLER, GREGORY AARON 2197 §101§102 Non-Final OA — Pending Oct 03, 2024
18853736 Cancer Treatments Using MTA-Cooperative PRMT5 Inhibitors MCKOY, QUINCY ANDRE 1626 §103§112DP Non-Final OA — Pending Oct 03, 2024
18845286 PACKAGING FOR DRUG DELIVERY DEVICE TECCO, ANDREW M 3731 §102§103§112 Non-Final OA — Pending Sep 09, 2024
18845273 OPTIMIZED TRANSFECTION PROTOCOL CORDAS, EMILY ANN 1632 §103 Non-Final OA — Pending Sep 09, 2024
18842194 A PROCESS FOR PREPARING 4-METHYL-2-PROPAN-2-YL-PYRIDINE-3-CARBONITRILE RAHMANI, NILOOFAR 1691 Other Final Rejection — Pending Aug 28, 2024
18807705 MACHINE LEARNING (ML)-BASED SYSTEMS AND METHODS FOR PREDICTING DISEASE EVANS, ASHLEY ELIZABETH 3687 §101§103 Non-Final OA 39d Pending Aug 16, 2024
18798878 AFLIBERCEPT ATTRIBUTES AND METHODS OF CHARACTERIZING AND MODIFYING THEREOF BORGEEST, CHRISTINA M 1675 §101§102§103§112 Non-Final OA — Pending Aug 09, 2024
18789085 DRUG DELIVERY DEVICE BOUCHELLE, LAURA A 3783 §102§103Other Non-Final OA — Pending Jul 30, 2024
18832887 SYNTHESIS OF A KIF18A INHIBITOR OH, TAYLOR V 1625 §102§112 Non-Final OA — Pending Jul 24, 2024
18730353 Crystalline Salt and Solvate Forms Of Murizatoclax (AMG 397) DAHLIN, HEATHER RAQUEL 1629 §103§112DP Non-Final OA — Pending Jul 19, 2024
18730357 Crystalline Forms Of An MCL-1 Inhibitor SAMSELL, RILLA MARIE 1624 §102§103§112 Non-Final OA — Pending Jul 19, 2024
18744036 AUTOINJECTOR WITH SHOCK REDUCING ELEMENTS MEDWAY, SCOTT J 3783 §102§103 Non-Final OA — Pending Jun 14, 2024
18719164 METHODS FOR DESIGNING AND PERFORMING A VAPOR PHASE HYDROGEN PEROXIDE DECONTAMINATION CYCLE HOERNER, PAUL ELLSWORTH 1611 §112 Final Rejection — Pending Jun 12, 2024
18674549 INJECTION DEVICE FOR DRUG DELIVERY AND PACKAGING FOR THE INJECTION DEVICE PATEL, SHEFALI DILIP 3783 §102§103 Final Rejection — Pending May 24, 2024
18712768 STOPPER PLACEMENT IN A SYRINGE SEIF, DARIUSH 3731 §102§103§112 Non-Final OA — Pending May 23, 2024
18710112 PLUNGER ROD REMOVAL FORCE METHOD AND FIXTURE PATEL, SHEFALI DILIP 3783 §102§103§112 Non-Final OA — Pending May 14, 2024
18645779 CONTROLLABLE DRUG DELIVERY SYSTEM AND METHOD OF USE HALL, DEANNA K 3783 §102§103 Non-Final OA — Pending Apr 25, 2024
18701723 COMPOSITION AND METHODS FOR RECOMBINANT LENTIVIRAL PRODUCTION PRONZATI, GINA 1633 §103§112 Non-Final OA — Pending Apr 16, 2024
18698098 FC-GAMMA RECEPTOR II BINDING AND GLYCAN CONTENT EVANS, CHRISTOPHER RYAN 1677 §102§103§112 Non-Final OA — Pending Apr 03, 2024
18697770 CHARACTERIZATION APPARATUS FOR DRUG DELIVERY DEVICES OR SUBCOMPONENTS THEREOF NATH, SUMAN KUMAR 2855 §101 Non-Final OA — Pending Apr 02, 2024
18696946 Heterocyclic Compounds and Methods of Use CHAO, ALLEN 1622 §103DP Non-Final OA — Pending Mar 28, 2024
18611364 ST2 ANTIGEN BINDING PROTEINS MCCOLLUM, ANDREA K 1674 §101§112Other Non-Final OA — Pending Mar 20, 2024
18685037 MYOPEPTIDES AND METHODS OF USE IN TREATING HEART FAILURE CHERNYSHEV, OLGA N 1675 §112 Non-Final OA — Pending Feb 20, 2024
18684262 METHODS COMPRISING THERAPEUTIC COMPOUNDS AND IN VITRO MAMMALIAN SKIN CLARKE, TRENT R 1651 §101§103§112 Non-Final OA — Pending Feb 16, 2024
18435746 TIGIT AND CD112R BLOCKADE GAO, ASHLEY HARTMAN 1678 §112 Non-Final OA — Pending Feb 07, 2024
18681252 ISOLATION OF THERAPEUTIC PROTEIN HOLLAND, PAUL J 1656 §103 Final Rejection — Pending Feb 05, 2024
18291294 STEREOSELECTIVE PREPARATION OF TRANS HALO CYCLOBUTANE BAKSHI, PANCHAM 1623 §112 Final Rejection — Pending Jan 23, 2024
18571614 Treatment of Cardiovascular Disease with TREM-1 Antigen Binding Proteins PRIEST, JESSICA MARIE 1642 §112DP Non-Final OA — Pending Dec 18, 2023
18538279 ANTIBODY CONSTRUCTS FOR MSLN AND CD3 BRISTOL, LYNN ANNE 1643 §112DP Non-Final OA — Pending Dec 13, 2023
18535068 FORMULATIONS OF HUMAN ANTI-RANKL ANTIBODIES, AND METHODS OF USING THE SAME LANDSMAN, ROBERT S 1647 Other Final Rejection 21d Pending Dec 11, 2023
18564805 DRUG DELIVERY DEVICES, FINGER-GRIP ELEMENTS, AND RELATED METHODS DOUBRAVA, JOHN A 3783 §102 Final Rejection — Pending Nov 28, 2023
18561341 FEEDBACK SYSTEM AND METHOD FOR A DRUG PRODUCT CASILLASHERNANDEZ, OMAR 2689 §103 Final Rejection — Pending Nov 16, 2023
18289317 DOSING REGIMEN FOR COMBINATION THERAPY TARGETING DLL3 AND PD-1 DUTT, ADITI 1675 DP Non-Final OA — Pending Nov 02, 2023
18288410 ETELCALCETIDE FORMULATIONS LEE, JIA-HAI 1658 §103§112DP Non-Final OA — Pending Oct 26, 2023
18287593 ANTI-TSLP ANTIBODY COMPOSITIONS AND USES THEREOF MIDDLETON, DANAYA L 1674 §103§112DP Non-Final OA — Pending Oct 19, 2023
18381745 DUAL RECEPTOR ANTAGONISTIC ANTIGEN-BINDING PROTEINS AND USES THEREOF LI, RUIXIANG 1674 Other Non-Final OA — Pending Oct 19, 2023
18286702 Automated Outlier Removal for Multivariate Modeling BECK, LERON 2487 §103 Final Rejection — Pending Oct 12, 2023
18286242 SYSTEMS AND METHODS TO EVALUATE INACTIVATION KINETICS OF A BIOLOGICAL INDICATOR NEGIN, RUSSELL SCOTT 1686 §101§103 Non-Final OA — Pending Oct 10, 2023
18285125 MAGEB2 BINDING CONSTRUCTS JOHANSEN, PETER N. 1644 §112 Non-Final OA — Pending Sep 29, 2023
18284590 MODULATING PRODUCT QUALITY OF ASYMMETRIC MULTISPECIFIC ANTIBODIES THROUGH THE USE OF TEMPERATURE AEDER, SEAN E 1642 §103§112 Non-Final OA — Pending Sep 28, 2023
18550650 SOUND-DETECTION BASED INJECTION TIME MEASUREMENT SYSTEM FOR DRUG DELIVERY DEVICES FREHE, WILLIAM R 3783 §102§103 Non-Final OA — Pending Sep 14, 2023
18550647 DRUG DELIVERY DEVICE FREHE, WILLIAM R 3783 §102§103 Non-Final OA — Pending Sep 14, 2023
18550645 COMPONENT MATCHING DECISION SUPPORT TOOL CARTER, CHRISTOPHER W 2117 §102 Final Rejection — Pending Sep 14, 2023
18242116 LARGE SCALE BIOREACTOR SYSTEM AND METHOD BRIDGES, DONAVAN LEE 1758 §103§112 Non-Final OA — Pending Sep 05, 2023
18275855 NON-TERMINAL ANTIBODY DISCOVERY METHODS AND SINGLE CELL ASSAYS CHANDRA, GYAN 1674 §103§112 Non-Final OA — Pending Aug 04, 2023
18275550 SYSTEMS AND APPROACHES FOR DRUG PROCESSING WRIGHT, PATRICIA KATHRYN 1798 §103 Non-Final OA — Pending Aug 02, 2023
18270581 USE OF KRAS G12C INHIBITOR IN TREATING CANCERS HASTINGS, ALISON AZAR 1627 §102§103Other Final Rejection 23d overdue Pending Jun 30, 2023
18266689 DIFFUSION GRADIENT ASSAY FOR ANTI-CD3-CONTAINING MOLECULES SPENCE, JENNIFER SUZANNE 1633 §103§112 Final Rejection 12d Pending Jun 12, 2023
18038579 ENANTIOSELECTIVE ALKENYLATION OF ALDEHYDES MOORE, SUSANNA 1624 §103§112 Final Rejection 16d Pending May 24, 2023
18316739 Antibody Constructs for CLDN18.2 and CD3 MOSELEY II, NELSON B 1642 §112 Final Rejection 8d overdue Pending May 12, 2023
18252442 NOVEL LINKERS OF MULTISPECIFIC ANTIGEN BINDING DOMAINS SZPERKA, MICHAEL EDWARD 1641 §103Other Final Rejection — Pending May 10, 2023
18195155 MACHINE LEARNING TECHNIQUES FOR PREDICTING THERMOSTABILITY SABOUR, GHAZAL 1686 §101§103 Non-Final OA — Pending May 09, 2023
18251553 MATERIALS AND METHODS FOR PROTEIN PROCESSING BANERJEE, KOYELI 1658 §103DP Final Rejection 13d Pending May 03, 2023
18035054 METHODS FOR ADMINISTERING A BCMAXCD3 BINDING MOLECULE HADDAD, MAHER M 1641 §103DP Final Rejection 7d Pending May 02, 2023
18032765 DRUG DELIVERY DEVICE ASSEMBLY AND ACCESSORY FOR DRUG DELIVERY DEVICE RADOMSKI, MARTIN ADAM 3783 §102§103 Non-Final OA — Pending Apr 19, 2023
18031691 RELATIVE UNPAIRED GLYCANS IN ANTIBODY PRODUCTION METHODS ROBINSON, HOPE A 1652 §103§112DP Final Rejection — Pending Apr 13, 2023
18248345 RATIONAL SELECTION OF BUILDING BLOCKS FOR THE ASSEMBLY OF MULTISPECIFIC ANTIBODIES HUYNH, PHUONG N 1641 §103§112 Non-Final OA — Pending Apr 07, 2023
18296211 AMORPHOUS AND CRYSTALLINE FORMS OF MCL-1 ANTAGONISTS SANCHEZ, JUSTIN CHRISTOPHER 1622 §102§112Other Non-Final OA — Pending Apr 05, 2023
18026678 METHODS OF PROCESSING A SAMPLE FOR PEPTIDE MAPPING ANALYSIS ARMATO JR, DENNIS IGNATIUS 1651 §103§112 Non-Final OA 33d Pending Mar 16, 2023
18245004 METHODS OF DETECTING ISOASPARTIC ACID XU, XIAOYUN 1797 §103 Non-Final OA 28d Pending Mar 13, 2023
18025311 Predicting Shelf Life Stability of Lyophilized Drug Products TAMIRU, ABRHAM ALEHEGN 2188 §101§103 Non-Final OA — Pending Mar 08, 2023
18044158 MATERIALS AND METHODS TO REDUCE PROTEIN AGGREGATION ALLEN, MARIANNE P 1647 §103 Non-Final OA — Pending Mar 06, 2023
18042267 ANTIGEN BINDING PROTEINS WITH NON-CANONICAL DISULFIDE IN FAB REGION BRISTOL, LYNN ANNE 1643 §112 Final Rejection 93d overdue Pending Feb 20, 2023
18018389 CELL CULTURE MEDIA AND METHODS OF MAKING AND USING THE SAME VAN BUREN, LAUREN K 1638 §103§112 Final Rejection 153d overdue Pending Jan 27, 2023
18068922 MAMMALIAN CELL CULTURE POPA, ILEANA 1633 Other Non-Final OA — Pending Dec 20, 2022
18002303 METHODS OF MEASURING CARFILZOMIB XU, XIAOYUN 1797 §103 Final Rejection — Pending Dec 19, 2022
18009682 CYCLOPROPYL DIHYDROQUINOLINE SULFONAMIDE COMPOUNDS RODRIGUEZ, RAYNA B 1628 §103Other Final Rejection — Pending Dec 09, 2022
18007560 RNAI CONSTRUCTS FOR INHIBITING HSD17B13 EXPRESSION AND METHODS OF USE THEREOF SHIN, DANA H 1635 §103§112 Final Rejection — Pending Dec 01, 2022
17928561 ANTIBODY FORMULATIONS AND USES THEREOF KIM, YUNSOO 1641 §103DP Final Rejection 85d overdue Pending Nov 29, 2022
17921794 PHARMACEUTICAL FORMULATION SKELDING, ZACHARY S 1644 §102§103Other Final Rejection — Pending Oct 27, 2022
17921793 PHARMACEUTICAL FORMULATION KAUFMAN, CLAIRE M 1674 §102§112DP Final Rejection 17d overdue Pending Oct 27, 2022
17916843 Synthesis of vinylic alcohol intermediates HAVLIN, ROBERT H 1626 §103Other Final Rejection 15d overdue Pending Oct 04, 2022
17911510 CONTROLLED DISPENSE SYRINGE GRAY, PHILLIP A 3783 §102 Final Rejection — Pending Sep 14, 2022
17930810 ADAPTATION OF PLATFORM HOSTS TO IGF- MEDIA MOORE, JOHN DAVID 1638 §103 Non-Final OA — Pending Sep 09, 2022
17821835 Method of Antigen-Binding Protein Production MARCSISIN, ELLEN JEAN 1677 §103Other Non-Final OA 182d overdue Pending Aug 24, 2022
17793757 COMBINATIONS OF ANTIBODY CONSTRUCTS AND INHIBITORS OF CYTOKINE RELEASE SYNDROME AND USES THEREOF LU, CHENG 1642 §103Other Non-Final OA — Pending Jul 19, 2022
17810142 STABLE CYCLODEXTRIN FREE CARFILZOMIB FORMULATION BASQUILL, SEAN M 1614 §103 Final Rejection — Pending Jun 30, 2022
17846310 SYRINGES, ASSEMBLIES, AND METHODS OF MANUFACTURE BOUCHELLE, LAURA A 3783 §103 Non-Final OA — Pending Jun 22, 2022
17834518 METHODS OF PROTEIN CLIPS RECOVERY CHIN, CHRISTOPHER L 1677 §112DP Non-Final OA — Pending Jun 07, 2022
17780596 FLOW RESTRICTOR FOR DRUG DELIVERY DEVICE THOMAN, EVELYN ANNE 3783 §103§112 Non-Final OA — Pending May 27, 2022
17778361 NOVEL MULTISPECIFIC ANTIBODY FORMAT DONOGHUE, BRITTNEY ERIN 1675 §103 Final Rejection 19d overdue Pending May 19, 2022
17775386 Method for Reduced Aggregate Formation in Downstream Processing of Bispecific Antigen-Binding Molecules SKELDING, ZACHARY S 1644 §103§112 Final Rejection 52d overdue Pending May 09, 2022
17775063 ENGINEERING CHARGE PAIR MUTATIONS FOR PAIRING OF HETERO-IgG MOLECULES DUFFY, BRADLEY 1643 §102 Final Rejection 45d overdue Pending May 06, 2022
17775257 METHOD OF TREATING OR AMELIORATING CUSHING'S SYNDROME USING BINDING PROTEINS FOR GASTRIC INHIBITORY PEPTIDE RECEPTOR (GIPR) ALLEN, MARIANNE P 1647 §103DP Final Rejection 87d overdue Pending May 06, 2022
17774232 MULTITARGETING ANTIGEN-BINDING MOLECULES FOR USE IN PROLIFERATIVE DISEASES KAUFMAN, CLAIRE M 1674 §102§103§112 Non-Final OA — Pending May 04, 2022
17773886 HIGH SALT LOAD CONDITIONING DURING CATION EXCHANGE CHROMATOGRAPHY TO REMOVE PRODUCT-RELATED IMPURITIES DEBERRY, REGINA M 1647 DP Final Rejection 88d overdue Pending May 03, 2022
17771313 COMPOSITIONS AND METHODS FOR MINIMIZING PROTEIN LOSS AT LOW PROTEIN CONCENTRATIONS XIE, XIAOZHEN 1674 §103 Non-Final OA 5d Pending Apr 22, 2022
17770341 DRUG DELIVERY DEVICE AND SYSTEM WITTLIFF, KATERINA ANNA 3783 §102§103§112 Non-Final OA — Pending Apr 20, 2022
17767471 DRUG DELIVERY DEVICE AND SYSTEM KOO, BENJAMIN K 3783 §103 Final Rejection — Pending Apr 08, 2022
17767469 DRUG DELIVERY DEVICE AND SYSTEM WITTLIFF, KATERINA ANNA 3783 §103 Final Rejection — Pending Apr 08, 2022
17767111 DRUG DELIVERY DEVICE TAYLOR, MARISSA ENVENESIA 3783 §102§103§112 Non-Final OA — Pending Apr 07, 2022
17763692 DRUG PRODUCT CONTAINER AND DRUG DELIVERY SYSTEM PAZ ESTEVEZ, GUILLERMO G 3783 §103 Final Rejection — Pending Mar 25, 2022
17630207 DRUG DELIVERY DEVICE WITH TEMPERATURE MEASUREMENT AND RELATED METHOD HALL, DEANNA K 3783 §102 Non-Final OA — Pending Jan 26, 2022
17630270 DRUG DELIVERY DEVICE WITH CONFIGURABLE NEEDLE SHIELD ENGAGEMENT COMPONENTS AND RELATED METHODS MARRISON, SAMUEL JOSEPH 3783 §103 Non-Final OA 26d Pending Jan 26, 2022
17621135 Wireless Communication Enabled Drug Delivery Device and Method PAZ ESTEVEZ, GUILLERMO G 3783 §102§103 Non-Final OA — Pending Dec 20, 2021
17616580 BISPECIFIC BINDING CONSTRUCTS MELCHIOR, JAMES RYLAND 1644 §103DP Final Rejection — Pending Dec 03, 2021
17615520 RNAI CONSTRUCTS FOR INHIBITING SCAP EXPRESSION AND METHODS OF USE THEREOF SULLIVAN, STEPHANIE LAUREN 1635 §103DP Final Rejection 1d overdue Pending Nov 30, 2021
17514763 PLUNGERS FOR DRUG DELIVERY DEVICES RITCHIE, HADEN MATTHEW 3783 §103 Final Rejection — Pending Oct 29, 2021
17602148 DRUG DELIVERY DEVICE WITH SMART GRIP DIOP, FATIMATA SAHRA 3783 §102§103 Non-Final OA — Pending Oct 07, 2021
17599656 PREDICTING CELL CULTURE PERFORMANCE IN BIOREACTORS SCHULTZHAUS, JANNA NICOLE 1685 §103 Final Rejection 36d overdue Pending Sep 29, 2021
17599028 USE OF ONCOLYTIC VIRUSES IN THE NEOADJUVANT THERAPY OF CANCER ROGERS, ERIC JASON 1638 §102§103§112 Non-Final OA — Pending Sep 28, 2021
17441021 INJECTOR ACCESSORIES FARRAR, LAUREN PENG 3783 §103 Non-Final OA — Pending Sep 20, 2021
17436218 IN VIVO REVERSIBILITY OF HIGH MOLECULAR WEIGHT SPECIES FRITCHMAN, REBECCA M 1758 §101§103 Non-Final OA 8d Pending Sep 03, 2021
17419406 CONTINUOUS DOSING SYSTEMS AND APPROACHES GOLLAMUDI, NEERAJA 3783 §112 Final Rejection — Pending Jun 29, 2021
17277533 PLATFORM ASSEMBLY PROCESS FOR DRUG DELIVERY DEVICE LALONDE, ALEXANDRA ELIZABETH 3783 §103§112 Final Rejection 65d Pending Mar 18, 2021
17036690 DRUG DELIVERY DEVICE LALONDE, ALEXANDRA ELIZABETH 3783 §102§103 Non-Final OA 22d Pending Sep 29, 2020
16898628 DRUG DELIVERY DEVICE WITH A ROTATABLE DRIVE MECHANISM RADOMSKI, MARTIN ADAM 3783 §103§112 Non-Final OA — Pending Jun 11, 2020
16771641 METHOD OF TREATING IDIOPATHIC THROMBOCYTOPENIA PURPURA (ITP) WITH ROMIPLOSTIM DABKOWSKI, ERINNE R 1654 §102§112 Non-Final OA — Pending Jun 10, 2020
16763515 METHODS FOR PRODUCING PROTEIN PRODUCTS HURST, JONATHAN M 1799 §103 Final Rejection 162d overdue Pending May 12, 2020
16869793 DOSING REGIMEN FOR ANTI-BCMA AGENTS BRISTOL, LYNN ANNE 1643 §112 Non-Final OA — Pending May 08, 2020
16348653 COMBINED THERAPIES FOR ATHEROSCLEROSIS, INCLUDING ATHEROSCLEROTIC CARDIOVASCULAR DISEASE WEN, SHARON X 1641 §103DP Non-Final OA — Pending May 09, 2019
13931716 METHODS FOR TREATING OR PREVENTING CHOLESTEROL RELATED DISORDERS WEN, SHARON X 1641 §103DP Final Rejection 18d overdue Pending Jun 28, 2013
18704120 SUBCUTANEOUS ADMINISTRATION OF CD19-BINDING T CELL ENGAGERS CANELLA, KAREN A 1643 §103§112 Non-Final OA — Pending Apr 24, 2024
18430415 BISPECIFIC ANTIBODY CONSTRUCTS FOR CDH3 AND CD3 NATARAJAN, MEERA 1643 §112DP Non-Final OA — Pending Feb 01, 2024
18556998 METHODS FOR REDUCING LOW MOLECULAR WEIGHT SPECIES OF RECOMBINANTLY-PRODUCED PROTEINS SZPERKA, MICHAEL EDWARD 1641 §102§103§112 Non-Final OA — Pending Oct 24, 2023
18038880 Mechanistic Ion-Exchange Chromatography Model Calibration DARRIGRAND, EMILY ANN 2857 §101§102§103§112 Non-Final OA — Pending May 25, 2023
18038886 MOLECULES WITH MULTIPLE BINDING DOMAINS PETERS, ALEC JON 1641 §103§112DP Non-Final OA — Pending May 25, 2023
18314577 Single chain binding molecules comprising N-terminal ABP SKELDING, ZACHARY S 1644 DP Non-Final OA — Pending May 09, 2023
18251133 ANTIGEN BINDING DOMAIN WITH REDUCED CLIPPING RATE BOWLES, DAVID PAUL 1654 §102§103DP Non-Final OA — Pending Apr 28, 2023
18026505 METHODS FOR ADMINISTERING THERAPEUTIC DOSES OF BISPECIFIC T-CELL ENGAGING MOLECULES FOR THE TREATMENT OF CANCER MELCHIOR, JAMES RYLAND 1644 §103 Non-Final OA — Pending Mar 15, 2023
18164304 TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA DUFFY, BRADLEY 1643 §102§103§112DP Non-Final OA — Pending Feb 03, 2023
18066972 CROSS-SPECIES-SPECIFIC BINDING DOMAIN DUFFY, BRADLEY 1643 §102DP Non-Final OA — Pending Dec 15, 2022
17932739 TREATMENT OF PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA HOLTZMAN, KATHERINE ANN 1646 §103§112DP Non-Final OA — Pending Sep 16, 2022
17775543 DOSAGE REGIMEN FOR ANTI-EGFRVIII AGENTS CHASE, CAROL ANN 1646 §103§112DP Non-Final OA 86d overdue Pending May 09, 2022
17480504 Means and Methods for Treating Tumorous Diseases MOSELEY II, NELSON B 1642 §103 Final Rejection — Pending Sep 21, 2021
16586318 CROSS-SPECIES-SPECIFIC BISPECIFIC BINDERS SKELDING, ZACHARY S 1644 §112 Non-Final OA 77d overdue Pending Sep 27, 2019

Data sourced from USPTO Patent File Wrapper (daily) and Office Action Archive (weekly). Analysis generated by IP Author.

Data: USPTO Patent File Wrapper (daily) • Office Action Archive (weekly) • 89M+ prosecution events

© 2026 IP Author — Browse Office Actions • Examiners • Companies • Firms

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month